Cargando…
Tumor targeting using liposomal antineoplastic drugs
During the last years, liposomes (microparticulate phospholipid vesicles) have been used with growing success as pharmaceutical carriers for antineoplastic drugs. Fields of application include lipid-based formulations to enhance the solubility of poorly soluble antitumor drugs, the use of pegylated...
Autores principales: | Huwyler, Jörg, Drewe, Jürgen, Krähenbühl, Stephan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2526358/ https://www.ncbi.nlm.nih.gov/pubmed/18488413 |
Ejemplares similares
-
Therapeutic drug monitoring of oral targeted antineoplastic drugs
por: Mueller-Schoell, Anna, et al.
Publicado: (2020) -
Resistance to antineoplastic drugs
por: Twentyman, Peter
Publicado: (1990) -
Clinical Pharmacology of Antineoplastic Drugs
por: Stewart, A.
Publicado: (1979) -
Spontaneous In Situ Formation of Liposomes from Inert Porous Microparticles for Oral Drug Delivery
por: Farzan, Maryam, et al.
Publicado: (2020) -
Arsenic-Based Antineoplastic Drugs and Their Mechanisms of Action
por: Ralph, Stephen John
Publicado: (2008)